Gross Profit Summary of Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation's latest annual gross profit in 2023 was 173.91 Million TWD , down -13.66% from previous year.
Abnova (Taiwan) Corporation's latest quarterly gross profit in 2024 Q1 was 40.95 Million TWD , down -9.36% from previous quarter.
Abnova (Taiwan) Corporation reported a annual gross profit of 201.42 Million TWD in annual gross profit 2022, up 2.07% from previous year.
Abnova (Taiwan) Corporation reported a annual gross profit of 197.33 Million TWD in annual gross profit 2021, down -7.57% from previous year.
Abnova (Taiwan) Corporation reported a quarterly gross profit of 40.95 Million TWD for 2024 Q1, down -9.36% from previous quarter.
Abnova (Taiwan) Corporation reported a quarterly gross profit of 40.61 Million TWD for 2023 Q3, down -6.0% from previous quarter.

Annual Gross Profit Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Gross Profit of Abnova (Taiwan) Corporation (2023 - 2009)

Year	Gross Profit	Gross Profit Growth
2023	173.91 Million TWD	-13.66%
2022	201.42 Million TWD	2.07%
2021	197.33 Million TWD	-7.57%
2020	213.5 Million TWD	15.19%
2019	185.35 Million TWD	-0.02%
2018	185.38 Million TWD	-19.0%
2017	228.86 Million TWD	10.75%
2016	206.65 Million TWD	-3.3%
2015	213.7 Million TWD	-4.49%
2014	223.75 Million TWD	-5.27%
2013	236.18 Million TWD	-7.1%
2012	254.22 Million TWD	-5.33%
2011	268.53 Million TWD	-4.66%
2010	281.66 Million TWD	22.03%
2009	230.82 Million TWD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	38.2 Million TWD	-6.7%
2024 Q1	40.95 Million TWD	-9.36%
2023 Q3	40.61 Million TWD	-6.0%
2023 Q1	44.92 Million TWD	-17.38%
2023 FY	173.91 Million TWD	-13.66%
2023 Q2	43.2 Million TWD	-3.82%
2023 Q4	45.18 Million TWD	11.25%
2022 FY	201.42 Million TWD	2.07%
2022 Q2	50.1 Million TWD	4.86%
2022 Q3	49.17 Million TWD	-1.86%
2022 Q4	54.37 Million TWD	10.57%
2022 Q1	47.78 Million TWD	24.2%
2021 Q2	53.69 Million TWD	4.25%
2021 Q1	51.5 Million TWD	-8.3%
2021 Q4	38.47 Million TWD	-28.3%
2021 FY	197.33 Million TWD	-7.57%
2021 Q3	53.66 Million TWD	-0.07%
2020 Q3	64.62 Million TWD	38.35%
2020 FY	213.5 Million TWD	15.19%
2020 Q1	45.99 Million TWD	-7.66%
2020 Q2	46.71 Million TWD	1.55%
2020 Q4	56.17 Million TWD	-13.08%
2019 Q3	48.98 Million TWD	11.67%
2019 FY	185.35 Million TWD	-0.02%
2019 Q1	42.67 Million TWD	1.37%
2019 Q4	49.81 Million TWD	1.69%
2019 Q2	43.87 Million TWD	2.79%
2018 Q3	48.67 Million TWD	-1.92%
2018 Q2	49.62 Million TWD	10.33%
2018 FY	185.38 Million TWD	-19.0%
2018 Q4	42.1 Million TWD	-13.5%
2018 Q1	44.97 Million TWD	-10.49%
2017 Q2	57.17 Million TWD	-3.27%
2017 Q4	50.24 Million TWD	-19.39%
2017 Q1	59.1 Million TWD	20.92%
2017 FY	228.86 Million TWD	10.75%
2017 Q3	62.33 Million TWD	9.03%
2016 Q2	51.34 Million TWD	-8.68%
2016 FY	206.65 Million TWD	-3.3%
2016 Q4	48.87 Million TWD	-2.66%
2016 Q3	50.21 Million TWD	-2.2%
2016 Q1	56.22 Million TWD	6.33%
2015 FY	213.7 Million TWD	-4.49%
2015 Q4	52.87 Million TWD	18.16%
2015 Q2	71.89 Million TWD	62.69%
2015 Q3	44.74 Million TWD	-37.76%
2015 Q1	44.19 Million TWD	-23.97%
2014 Q3	55.95 Million TWD	1.89%
2014 FY	223.75 Million TWD	-5.27%
2014 Q4	58.12 Million TWD	3.87%
2014 Q2	54.92 Million TWD	0.3%
2014 Q1	54.75 Million TWD	2.84%
2013 Q3	55.37 Million TWD	-7.81%
2013 Q4	53.24 Million TWD	-3.85%
2013 FY	236.18 Million TWD	-7.1%
2013 Q1	67.5 Million TWD	9.15%
2013 Q2	60.06 Million TWD	-11.02%
2012 Q3	59.86 Million TWD	1.27%
2012 FY	254.22 Million TWD	-5.33%
2012 Q4	61.84 Million TWD	3.3%
2012 Q2	59.11 Million TWD	-19.96%
2012 Q1	73.86 Million TWD	4.29%
2011 Q3	63.46 Million TWD	-4.15%
2011 Q4	70.82 Million TWD	11.6%
2011 FY	268.53 Million TWD	-4.66%
2011 Q1	68.04 Million TWD	2.05%
2011 Q2	66.21 Million TWD	-2.69%
2010 Q1	67.17 Million TWD	0.0%
2010 FY	281.66 Million TWD	22.03%
2010 Q3	74.72 Million TWD	2.22%
2010 Q4	66.67 Million TWD	-10.77%
2010 Q2	73.1 Million TWD	8.82%
2009 FY	230.82 Million TWD	0.0%

Peer Gross Profit Comparison of Abnova (Taiwan) Corporation

Name	Gross Profit	Gross Profit Difference
Apex Biotechnology Corp.	531.11 Million TWD	67.255%
Sinphar Pharmaceutical Co.,Ltd.	1.09 Billion TWD	84.063%
Panion & Bf Biotech Inc.	912.56 Million TWD	80.942%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	757.3 Million TWD	77.035%
GenMont Biotech Incorporation	177.33 Million TWD	1.929%
Adimmune Corporation	410.93 Million TWD	57.678%
Tanvex BioPharma, Inc.	59.7 Million TWD	-191.31%
Polaris Group	-137.9 Million TWD	226.116%
Energenesis Biomedical CO.,LTD.	5.22 Million TWD	-3227.243%
UnicoCell Biomed Co., Ltd.	17.89 Million TWD	-871.755%
PELL Bio-Med Technology Co. Ltd.	-26.14 Million TWD	765.321%

Global Stocks Search

Abnova (Taiwan) Corporation (4133.TW)

Gross Profit Summary of Abnova (Taiwan) Corporation

Annual Gross Profit Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Gross Profit of Abnova (Taiwan) Corporation (2023 - 2009)

Peer Gross Profit Comparison of Abnova (Taiwan) Corporation